Advisory Commission on Childhood Vaccines; Notice of Meeting, 46911 [E8-18630]

Download as PDF 46911 Federal Register / Vol. 73, No. 156 / Tuesday, August 12, 2008 / Notices TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1—Continued 21 CFR Section 607.21, 607.25, 607.30(a), 607.31, and 607.40 Form FDA 2830 No. of Respondents Product Listing Update Annual Frequency per Response 180 Total Annual Responses 1 Hours Per Response 180 Total 1 There 45 1,467 are no capital costs or operating and maintenance costs associated with this collection of information. Please note that on January 15, 2008, the FDA Division of Dockets Management Web site transitioned to the Federal Dockets Management System (FDMS). FDMS is a Government-wide, electronic docket management system. Electronic comments or submissions will be accepted by FDA only through FDMS at http://www.regulations.gov. Dated: August 5, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E8–18570 Filed 8–11–08; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: September 4, 2008, 1 p.m. to 5 p.m. EDT. September 5, 2008, 8 a.m. to 12 p.m. EDT. Place: Parklawn Building (and via audio conference call), Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857. The ACCV will meet on Thursday, September 4 from 1 p.m. to 5 p.m. (EDT) and Friday, September 5 from 9 a.m. to 12 p.m. (EDT). The public can join the meeting via audio conference call by dialing 1–888–220– 3083 on September 4 & 5 and providing the following information: Leader’s Name: Dr. Geoffrey Evans. Password: ACCV. Agenda: The agenda items for the September meeting will include, but are not limited to: updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration). Agenda VerDate Aug<31>2005 16:24 Aug 11, 2008 Jkt 214001 items are subject to change as priorities dictate. Public Comments: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Michelle Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: mherzog@hrsa.gov. Requests should contain the name, address, telephone number, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the comment period. These persons will be allocated time as it permits. FOR FURTHER INFORMATION CONTACT: Advisory Commission on Childhood Vaccines; Notice of Meeting sroberts on PROD1PC70 with NOTICES 0.25 Total Hours Anyone requiring information regarding the ACCV should contact Michelle Herzog, DVIC, HSB, HRSA, Room 11C– 26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443–6593 or email: mherzog@hrsa.gov. Dated: August 7, 2008. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E8–18630 Filed 8–11–08; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Training in Primary Care Medicine and Dentistry; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Training in Primary Care Medicine and Dentistry (ACTPCMD). PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Date and Time: September 15, 2008, 10 a.m.–1 p.m. Eastern Standard Time (EST). Place: (Audio Conference Call). Status: The meeting will be open to the public; audio conference access limited only by availability of telephone ports. Purpose: The Advisory Committee provides advice and recommendations on a broad range of issues dealing with programs and activities authorized under section 747 of the Public Health Service Act as amended by The Health Professions Education Partnership Act of 1998, Public Law 105– 392. At this meeting the Advisory Committee will finalize its seventh report on the topic of primary care providing a medical/dental home within the health care system. It will begin work on its eighth report on the topic of the redesign of primary care and its impact on training and Title VII, section 747. Reports are submitted to Congress and to the Secretary of the Department of Health and Human Services. Agenda: The agenda includes final approval of the recommendations and finalization of the seventh report as a whole. The Advisory Committee will plan the process for completion of the eighth report on the redesign of primary care training. An opportunity will be provided for public comment. Agenda items are subject to change as dictated by the priorities of the Advisory Committee. Supplementary Information: The ACTPCMD will convene on Monday, September 15 from 10 a.m. to 1 p.m. EST via audio conference. To participate in this audio conference call, please dial the toll-free number 1–800–475–0478 and provide the numeric passcode: 2219205. Anyone interested in participating in the audio conference should notify either Jerilyn K. Glass, M.D., Ph.D., or Anne F. Patterson by calling 301–443–6822 prior to September 8. For Further Information Contact: Anyone requesting information regarding the Advisory Committee should contact Jerilyn K. Glass, Designated Federal Official for the ACTPCMD, Bureau of Health Professions, Health Resources and Services Administration, Room 9A–27, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 443–6822. The Web address for information on the Advisory Committee is http://bhpr.hrsa.gov/ medicine-dentistry/actpcmd. Dated: August 7, 2008. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E8–18631 Filed 8–11–08; 8:45 am] BILLING CODE 4165–15–P E:\FR\FM\12AUN1.SGM 12AUN1

Agencies

[Federal Register Volume 73, Number 156 (Tuesday, August 12, 2008)]
[Notices]
[Page 46911]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18630]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: September 4, 2008, 1 p.m. to 5 p.m. EDT. 
September 5, 2008, 8 a.m. to 12 p.m. EDT.
    Place: Parklawn Building (and via audio conference call), 
Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
    The ACCV will meet on Thursday, September 4 from 1 p.m. to 5 
p.m. (EDT) and Friday, September 5 from 9 a.m. to 12 p.m. (EDT). The 
public can join the meeting via audio conference call by dialing 1-
888-220-3083 on September 4 & 5 and providing the following 
information:
    Leader's Name: Dr. Geoffrey Evans.
    Password: ACCV.
    Agenda: The agenda items for the September meeting will include, 
but are not limited to: updates from the Division of Vaccine Injury 
Compensation (DVIC), Department of Justice, National Vaccine Program 
Office, Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health), and Center for Biologics, 
Evaluation and Research (Food and Drug Administration). Agenda items 
are subject to change as priorities dictate.
    Public Comments: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Michelle Herzog, DVIC, Healthcare Systems 
Bureau (HSB), Health Resources and Services Administration (HRSA), 
Room 11C-26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: 
mherzog@hrsa.gov. Requests should contain the name, address, 
telephone number, and any business or professional affiliation of 
the person desiring to make an oral presentation. Groups having 
similar interests are requested to combine their comments and 
present them through a single representative. The allocation of time 
may be adjusted to accommodate the level of expressed interest. DVIC 
will notify each presenter by mail or telephone of their assigned 
presentation time. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may announce it 
at the time of the comment period. These persons will be allocated 
time as it permits.

FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding 
the ACCV should contact Michelle Herzog, DVIC, HSB, HRSA, Room 11C-26, 
5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443-6593 or e-
mail: mherzog@hrsa.gov.

    Dated: August 7, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E8-18630 Filed 8-11-08; 8:45 am]
BILLING CODE 4165-15-P